About Optimus Pharma
Optimus Pharma is a company based in Hyderabad (India) founded in 2004 was acquired by PAG in May 2022. It operates as a Direct-to-Consumer (D2C) and Reseller / Distribution. Optimus Pharma has raised $11.47 million across 3 funding rounds from investors including Unichem Labs, Srinivasa Rao Venkata Velivela and Kachana Kasturi. The company has 222 employees as of October 31, 2024. Optimus Pharma offers products and services including API, Formulations, and Molnupiravir. Optimus Pharma operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Hyderabad, India
- Employees 222 as on 31 Oct, 2024
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Optimus Pharma Pvt Ltd
-
Annual Revenue
$144.36 M (USD)2as on Mar 31, 2023
-
Net Profit
-$1.65 M (USD)-110as on Mar 31, 2023
-
EBITDA
$10.16 M (USD)-62as on Mar 31, 2023
-
Total Equity Funding
$11.47 M (USD)
in 3 rounds
-
Latest Funding Round
$9.91 M (USD), Series A
Nov 02, 2018
-
Investors
Unichem Labs
& 32 more
-
Employee Count
222
as on Oct 31, 2024
-
Acquired by
PAG
(May 11, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Optimus Pharma
Optimus Pharma offers a comprehensive portfolio of products and services, including API, Formulations, and Molnupiravir.
Active Pharmaceutical Ingredients are developed for global markets.
Finished formulations are produced for various therapeutic uses.
Antiviral drug is manufactured for emergency use authorization.
People of Optimus Pharma
Unlock access to complete
Leadership Team
3 people
Product Management Team
2 people
Sales and Marketing
1 people
Operations Team
1 people
Unlock access to complete
Funding Insights of Optimus Pharma
Optimus Pharma has successfully raised a total of $11.47M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $9.91 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Optimus Pharma
Optimus Pharma has secured backing from 33 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Unichem Labs, Srinivasa Rao Venkata Velivela and Kachana Kasturi.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Alternative investment firm
|
Locked | Locked | Locked | |
|
Branded formulations, APIs, and biosimilars are manufactured.
|
Locked | Locked | Locked | |
|
Steel products are manufactured by Twine Steel in Kolkata facilities.
|
Locked | Locked | Locked |
Investor details for Optimus Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Optimus Pharma
Investment portfolio details for Optimus Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Optimus Pharma
Detailed financials for Optimus Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Optimus Pharma Comparisons
Peer comparison for Optimus Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Optimus Pharma
Optimus Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Optimus Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Optimus Pharma
Complete news archive for Optimus Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Optimus Pharma
Optimus Pharma was founded in 2004 and raised its 1st funding round 10 years after it was founded.
Optimus Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Optimus Pharma is a funded company, having raised a total of $11.47M across 3 funding rounds to date.
As of Oct 31, 2024, the latest employee count at Optimus Pharma is 222.
Annual revenue of Optimus Pharma is $144.36M as on Mar 31, 2023.
Optimus Pharma is involved in the development and manufacturing of Active Pharmaceutical Ingredients (API), intermediates, and finished formulations for global markets. The company operates in the healthcare sector, focusing on research and development with a standalone lab employing over 150 scientists. Solutions are provided through synthetic chemistry, method development, and scale-up activities, ensuring high-quality and affordable products. Operations span across more than 40 countries with a strong emphasis on innovation and manufacturing excellence.
Optimus Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Optimus Pharma offers API, Formulations, and Molnupiravir.
Optimus Pharma has 33 investors. Key investors include Unichem Labs, Srinivasa Rao Venkata Velivela, Kachana Kasturi, Sunkireddy Rajashekar Reddy, and V Srivani.
The valuation of Optimus Pharma is $9.19M as of Mar 2016.